Investor Information

Supervisory Board

Stephen Belcher, Chairman of Supervisory Board

Mr. Belcher is a founder, principal, and Vice President of Triad Isotopes, which was formed in 2007 and has grown to 60 pharmacies and $270 million in sales. Mr. Belcher has contributed to the success of Triad as its architect and in numerous roles ranging from Vice President of Sales and Marketing to Vice President of Strategic Accounts. In this last role, Mr. Belcher helped secure over $300 million in growth opportunities over the last 2 years alone. Previously, Mr. Belcher served as an officer and principle architect of multiple successful new ventures. One of his companies was credited with establishing the first unit dose radiopharmaceutical sales in Puerto Rico. While growing the company, he managed a merger with a strategic partner and then worked with the partners to execute an exit strategy with Bristol Meyers Squibb. Mr. Belcher served as Chairman of the Board for the Association for Independent Nuclear Pharmacies and has extensive recognition throughout the nuclear medicine community. He serves on the boards of, or as an advisor to, multiple companies in the medical sector as well as having the privilege of serving on the board for Make a Wish Alabama.

Robert Louis Ferguson

Has over 45 years of management and technical experience in the government and private sectors. He previously served as Director of the Department of Energy Isotope Program, and as Deputy Assistant Secretary for Nuclear Programs within the U.S. Department of Energy, and former CEO of the Washington Public Power Supply System (now Energy Northwest). His government experience includes various roles for the Atomic Energy Commission, the Energy Research and Development Administration, and the U.S. Department of Energy.

Robert Schreiber

President of Schreiber, Yonley & Associates. He is an internationally recognized environmental engineer with over 25 years of experience. Prior to founding SYA, Mr. Schreiber was Vice President of Lafser and Schreiber Inc. Between 1974 and 1985 he held a variety of positions with the State of Missouri Department of Natural Resources including Director for Environmental Qualities and Director of Air Pollution Control.

David Waldman

Founded Crescendo Communications, LLC in 2006, a leading international investor relations and strategic advisory firm with offices in the U.S., Poland, Russia, and China. He has a long and successful track record working with private and publicly traded companies of all sizes and across a wide range of industries. He has built a reputation as a leading expert on financing and communications best practices

Matthew Molchan

Mr. Molchan is the President, CEO and a member of the Board of Directors of Digirad Corporation, one of the largest national providers of in-office nuclear cardiology and ultrasound imaging services. Mr. Molchan has held a variety of roles at Digirad including Chief Operating Officer of Digirad Ultrascan Solutions from May 2007 to January 2012, President of Digirad Imaging Solutions until January 2013, President of Digirad beginning January 2013, and most recently Chief Executive Officer of Digirad and a member of Digirad's Board of Directors since July 2013. Prior to joining Digirad, he held various executive level positions in business development, finance and operations at Ultrascan, Inc., Somera, Inc. and Equifax, Inc. He holds a Bachelor of Science degree in Economics from the United States Air Force Academy and a Masters of Business Administration in Finance from the University of Southern California.